Drug – bio-affecting and body treating compositions – Extract – body fluid – or cellular material of undetermined... – Hemic or immune system
Reexamination Certificate
2003-11-03
2010-02-09
Afremova, Vera (Department: 1657)
Drug, bio-affecting and body treating compositions
Extract, body fluid, or cellular material of undetermined...
Hemic or immune system
C424S520000, C435S372000
Reexamination Certificate
active
07658951
ABSTRACT:
A method of treating heart failure and improving cardiac function by administering stem cell products to a heart in need of treatment, whereby the stem cell products improve cardiac muscle function thereby treating heart failure and improving cardiac function. A method of enriching or regenerating damaged myocardium by administering stem cell products to damaged myocardium. Stem cell products for use in treating heart failure are also provided. A composition for enriching and regenerating damaged myocardium, the composition having stem cell products in a pharmaceutically acceptable carrier.
REFERENCES:
patent: 4666828 (1987-05-01), Gusella
patent: 4683202 (1987-07-01), Mullis
patent: 4801531 (1989-04-01), Frossard
patent: 5192659 (1993-03-01), Smulson et al.
patent: 5272057 (1993-12-01), Simons
patent: 6368636 (2002-04-01), McIntosh et al.
patent: 6387369 (2002-05-01), Pittenger et al.
patent: 7097832 (2006-08-01), Kornowski et al.
patent: 2002/0123143 (2002-09-01), Toma et al.
patent: 1 136 083 (2001-09-01), None
patent: 9903973 (1999-01-01), None
patent: 9949015 (1999-09-01), None
Pierpaolli et al. Cellular Immunology. 1981. 57: 219-228.
Hamano et al. Cell Transplantation. 2000, vol. 9, pp. 439-443.
Beresford, J. N.: Osteogenic Stem Cells and the connective Stromal System of Bone and Marrow, Clin. Orthop., 240:270,1989.
Burke and Olson, “Preparation of Clone Libraries in Yeast Artificial-Chromosome Vectors” inMethods in Enzymology, vol. 194, “Guide to Yeast Genetics and Molecular Biology”, eds. C. Guthrie and G. Fink, Academic Press, Inc., Chap. 17, pp. 251-270 (1991).
Capecchi, “Altering the genome by homologous recombination”Science244:1288-1292 (1989).
Cregg JM, Vedvick TS, Raschke WC: Recent Advances in the Expression of Foreign Genes inPichia pastoris, Bio/Technology 11:905-910, 1993.
Davies et al., “Targeted alterations in yeast artificial chromosomes for inter-species gene transfer”,Nucleic Acids Research, vol. 20, No. 11, pp. 2693-2698 (1992).
Gilboa, E, Eglitis, MA, Kantoff, PW, Anderson, WF: Transfer and expression of cloned genes using retroviral vectors. BioTechniques 4(6):504-512, 1986.
Huston et al, 1991 “Protein engineering of single-chain Fv analogs and fusion proteins” in Methods in Enzymology (JJ Langone, ed.; Academic Press, New York, NY) 203:46-88.
Jackson KA, Majka SM, Wang H, Pocius J, Hartley CJ, Majesky MW, Entman ML, Michael LH, Hirschi KK, Goodell MA. Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J Clin Invest Jun. 2001;107(11):1395-402.
Jakobovits et al., “Germ-line transmission and expression of a human-derived yeast artificial chromosome”,Nature, vol. 362, pp. 255-261 (1993).
Lamb et al., “Introduction and expression of the 400 kilobaseprecursor amyloid proteingene in transgenic mice”,Nature Genetics, vol. 5, pp. 22-29 (1993).
Maltsev VA, Rohwedel J, Hescheler J, Wobus AM: Embryonic stem cells differentiate in vitro into cardiomyocytes representing sinusnodal, artrial and ventricular cell types.Mechanisms of Development, 1994; 191:41-50.
Maltsev VA, Wobus AM, Rohwedel J, Bader M, Hescheler J. Cardiomyocytes differentiated in vitro from embryonic stem cells developmentally express cardiac-specific genes and ionic currents.Circulation Research, 1994; 75(2):233-244.
Mernaugh and Mernaugh, 1995 “An overview of phage-displayed recombinant antibodies” in Molecular Methods In Plant Pathology (RP Singh and US Singh, eds.; CRC Press Inc., Boca Raton, FL) pp. 359-365.
Orlic D, Kajstura J, Chimenti S, Jakoniuk I, Anderson SM, Li B, Pickel J, McKay R, Nadal-Ginard B, Bodine DM, Leri A, Anversa P. Bone marrow cells regenerate infracted myocardium. Nature. Apr. 5, 2001;410(6829):640-1.
Pearson and Choi,Expression of the human b-amyloid precursor protein gene from a yeast artificial chromosome in transgenic mice. Proc. Natl. Acad. Sci. USA, 1993. 90:10578-82.
Rothstein, “Targeting, disruption, replacement, and allele rescue: integrative DNA transformation in yeast” inMethods in Enzymology, vol. 194, “Guide to Yeast Genetics and Molecular Biology”, eds. C. Guthrie and G. Fink, Academic Press, Inc., Chap. 19, pp. 281-301 (1991).
Sabbah HN, Stein PD, Kono T, Gheorghiade M, Levine TB, Jafri S, Hawkins ET, Goldstein S. A canine model of chronic heart failure produced by multiple sequential coronary microembolizations.American Journal of Physiology. 1991; 260:H1379-84.
Sabbah, HN. Apoptotic cell death in heart failure. Cardiovasc Res. 2000 45:704-712.
Schedl et al., “A yeast artificial chromosome covering the tyrosinase gene confers copy number-dependent expression in transgenic mice”,Nature, vol. 362, pp. 258-261 (1993).
Strauss et al., “Germ line transmission of a yeast artificial chromosome spanning the murine a1(I) collagen locus”,Science, vol. 259, pp. 1904-1907 (1993).
Wang JS, Shum-Tim D, Galipeau J, Chedrawy E, Eliopoulos N, Chiu RC. Marrow stromal cells for cellular cardiomyoplasty: feasibility and potential clinical advantages. J Thorac Cardiovasc Surg. 2000.
Aoki, M., et al. Beneficial Angiogenesis Induced by Over-Expression of Human Hepatocyte Growth Factor (HGF) in Non-Infarcted and Infarcted Myocardium: Potential Gene Therapy for Myocardial Infarction. Circulation, American Hearth Association, vol. 98, No. 17, suppl, Oct. 27, 1998, pp. I-321.
Esakof, D., et al. Intraoperative Multiplane Transesophageal Echocardiography for Guiding Direct Myocardial Gene Transfer of Vascular Endothelial Growth Factor in Patents with Refractory Angina Pectoris. Human Gene Therapy vol. 10:2307-2314 (Sep. 20, 1999).
Grant, Derrick S., et al. Scatter factor induces blood vessel formation in vivo. Proc. Natl. Acad. Sci. USA, vol. 90, pp. 1937-1941, Mar. 1993.
Harada, K., et al. Vascular endothelial growth factor administration in chronic myocardial ischemia. 1996 The American Physiological Society. H1791-1802.
Heath, Carole A., et al. Cells for tissue engineering. Trends in Biotechnology, Jan. 2000 (Vo. 18) 17-19.
Kaye, D., et al. Reduced Myocardial Nerve Growth Factor Expression in Human and Experimental Heart Failure. Circ Res. vol. 100, No. 18 suppl., 2000;86:e80-e84.
Klug, M., et al. Genetically Selected Cardiomyocytes from Differentiating Embryonic Stem Cells Form Stable Intracardiac Grafts. J. Clin. Invest. The American Society for Clinical Investigations, Inc. vol. 98, No. 1, Jul. 1996. 216-224.
Landau, C., et al. Intrapericardial basic fibroblast growth factor induces myocardial angiogenesis in a rabbit model of chronic ischemia. American Heart Journal, May 1995 924-931.
Morbidelli, L., et al. Nitric Oxide Mediates Mitogenic Effect of VEGF on Coronary Venular Endothelium. American Journal of Physiology: Heart and Circulatory Physiology, The American Physiological Society, vo. 270, No. 1, part 2, 1996, pp. H411-H415.
Tomita, S., et al. Autotransplanted Mesenchymal Stem Cells Improve Function After a Myocardial Infarction.Circulation, American Heart Association, vo.. 98, No. 17, suppl, Oct. 27, 1998, pp. 1-200.
Ishigai Yukata
Maltsev Victor A.
Sabbah Hani N.
Sharov Viktor G.
Afremova Vera
Henry Ford Health System
LandOfFree
Method of improving cardiac function of a diseased heart does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of improving cardiac function of a diseased heart, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of improving cardiac function of a diseased heart will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4201323